Retina Global - Retinitis pigmentosa patients with a baseline central visual field diameter greater than 20 degrees had a profound response to jCell treatment in #jCyte, Inc.'s Phase 2b study, the largest
jCyte Shares Encouraging Update on Clinical Trial for Retinitis Pigmentosa | The Stem Cellar
UCI clinical trial targeting retinitis pigmentosa receives $6.6M grant from California Institute for Regenerative Medicine | School of Medicine | University of California, Irvine
Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials | Cell Death & Disease
Study outlines use of intravitreal injection of allogeneic human retinal progenitor cells to treat RP
Stem/progenitor cell-based transplantation for retinal degeneration: a review of clinical trials | Cell Death & Disease
Clinical Trials and Natural History Studies for Usher Syndrome
UCI receives record $592 million in research funding for fiscal 2020-21 | UCI News | UCI
jCell Therapy | Retinitis Pigmentosa | Degenerative Retinal Disorders | jCyte Inc.
Stem cell therapy for retinitis pigmentosa found safe, well-tolerated in first-stage clinical trial | UCI News | UCI
Rebecca Kammer - Vice President of Clinical Operations - jCyte, Inc. | LinkedIn
ARVO 2018: Dr. Henry Klassen Provides Update on jCyte Stem Cell Trials
Clinical Trials and Natural History Studies for Usher Syndrome
Research focuses on use of intravitreal injection of allogeneic human retinal progenitor cells to treat RP
Retinitis Pigmentosa Archives - Global Genes
jCyte Announces Promising Phase IIb Results for Allogeneic Retinal Stem Cell Therapy | BioSpace
Regenerative Medicine In Ophthalmology
Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell) for Treatment of Retinitis Pigmentosa | California's Stem Cell Agency
Comet Creative - jCyte's new website gave the company further credibility to raise capital for a clinical trial. The straight-forward content easily translates the complexity of the firm's retinitis pigmentosa drug research
jCyte starts second phase of stem cell clinical trial targeting vision loss | The Stem Cellar
jCyte Inc. Announces Promising Results In Retinitis Pigmentosa | The Optical Journal
jCyte Inc. Announces Promising Phase 2b Results of jCell Therapy in Retinitis Pigmentosa | Business Wire
jCell Therapy | Retinitis Pigmentosa | Degenerative Retinal Disorders | jCyte Inc.
Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell) for Treatment of Retinitis Pigmentosa | California's Stem Cell Agency
Hardy AIM 🎯 on Twitter: "#RENE 🧬 What is a PSC? A Pluripotent Stem Cell Pluripotent Stem Cells hailed a 🔥“big revolution”🔥 for the advancement of cell Therapy 🔥”Miraculous Cells”🔥 Is quite
